PCN241 COSTS OF CYTOKINE RELEASE SYNDROME (CRS) AND NEUROLOGICAL EVENTS (NE) IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL (LISO-CEL) IN THE TRANSCEND NHL 001 CLINICAL TRIAL: A MICRO-COSTING STUDY FROM THE SPANISH NATIONAL HEALTH SYSTEM (NHS) PERSPECTIVE
Presa, M., Varela, C., Oyagüez, I.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.436
Date:
November, 2019
File:
PDF, 379 KB
2019